Cardiol Therapeutics (CRDL) EPS (Basic) (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly EPS (Basic) came in at -$0.06 in Q1 2026, up 7.84% YoY from -$0.06 in Q1 2025, and up 27.15% on a QoQ basis from -$0.09 in Q3 2025.
Cardiol Therapeutics (CRDL) EPS (Basic) (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of EPS (Basic) data on file, last reported at -$0.06 in Q1 2026.
- Quarterly EPS (Basic) rose 7.84% year-over-year to -$0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.19 (up 28.79% YoY) and the FY2025 annual result came in at -$0.28, up 29.17% from the prior year.
- EPS (Basic) grew to -$0.06 in Q1 2026, from -$0.09 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q1 2026 to a low of -$0.16 in Q3 2022.
- A 5-year average of -$0.1 and a median of -$0.09 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 58.26% — and 2024, when it plunged 67.6%.
- Tracing CRDL's EPS (Basic) over 5 years: stood at -$0.1 in 2022, then advanced by 13.26% to -$0.09 in 2023, then tumbled by 67.6% to -$0.15 in 2024, then jumped by 41.18% to -$0.09 in 2025, then climbed by 27.15% to -$0.06 in 2026.
- The last three EPS (Basic) figures came in at -$0.06 (Q1 2026), -$0.09 (Q3 2025), and -$0.07 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.85 Bn | 39.19 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.40 Bn | 29.73 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.42 Bn | 15.03 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Cardiol Therapeutics | 218.11 Mn | 199.26 Mn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.07 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.09 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | -0.09 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.12 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -0.24 |
| Sep 30, 2021 | -0.19 |
| Jun 30, 2021 | -0.13 |
| Mar 31, 2021 | -0.20 |
| Dec 31, 2020 | -0.25 |
| Sep 30, 2020 | -0.10 |